Affigen

Affigen

Affigen

Affigen develops tumoridentifying therapies to treat cancer.
Founded
2016
Raised
$17M
Follow us
Alexa global traffic share
Latest funding
$17,000,000
Venture capital (Series A) - 2017
Black Beret Life Sciences
Team Size
2
Employees
PE HUB

Biotech company Affigen pulls in $17 mln Series A

Data leaks Messaging
$17,000,000 Venture capital (Series A)
FinSMEs

Affigen Closes $17m Series A Financing